Clinical Trial Update: Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing pre- and postoperative versus conventional adjuvant treatment in receptor-negative early stage breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Early Stage Breast Cancer | Phase 3 | Status: COMPLETED